Abliva AB Performance
| NEVPFDelisted Stock | USD 0.03 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Abliva AB are expected to decrease at a much lower rate. During the bear market, Abliva AB is likely to outperform the market. Abliva AB right now shows a risk of 0.0%. Please confirm Abliva AB variance, skewness, as well as the relationship between the Skewness and day typical price , to decide if Abliva AB will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Abliva AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Abliva AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 61.6 M | |
| Total Cashflows From Investing Activities | -1.1 M |
Abliva |
Abliva AB Relative Risk vs. Return Landscape
If you would invest 2.80 in Abliva AB on November 11, 2025 and sell it today you would earn a total of 0.00 from holding Abliva AB or generate 0.0% return on investment over 90 days. Abliva AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Abliva, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Abliva AB Target Price Odds to finish over Current Price
The tendency of Abliva Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.03 | 90 days | 0.03 | about 76.67 |
Based on a normal probability distribution, the odds of Abliva AB to move above the current price in 90 days from now is about 76.67 (This Abliva AB probability density function shows the probability of Abliva Pink Sheet to fall within a particular range of prices over 90 days) .
Abliva AB Price Density |
| Price |
Predictive Modules for Abliva AB
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Abliva AB. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Abliva AB Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Abliva AB is not an exception. The market had few large corrections towards the Abliva AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Abliva AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Abliva AB within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.38 | |
β | Beta against Dow Jones | -0.45 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | -0.22 |
Abliva AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abliva AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abliva AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Abliva AB is not yet fully synchronised with the market data | |
| Abliva AB has some characteristics of a very speculative penny stock | |
| Abliva AB has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 151 K. Net Loss for the year was (123.49 M) with loss before overhead, payroll, taxes, and interest of (103.54 M). | |
| Abliva AB has accumulated about 4.32 M in cash with (114.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Abliva AB Fundamentals Growth
Abliva Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Abliva AB, and Abliva AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abliva Pink Sheet performance.
| Return On Equity | -0.8 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 10.01 M | |||
| Shares Outstanding | 1.06 B | |||
| Price To Earning | (2.49) X | |||
| Price To Book | 0.60 X | |||
| Price To Sales | 765.58 X | |||
| Revenue | 151 K | |||
| EBITDA | (120.72 M) | |||
| Cash And Equivalents | 4.32 M | |||
| Cash Per Share | 0.06 X | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | (114.08 M) | |||
| Earnings Per Share | (0.11) X | |||
| Total Asset | 58.92 M | |||
| Retained Earnings | (29.41 M) | |||
| Current Asset | 13.44 M | |||
| Current Liabilities | 1.24 M | |||
About Abliva AB Performance
By analyzing Abliva AB's fundamental ratios, stakeholders can gain valuable insights into Abliva AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Abliva AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abliva AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Abliva AB develops medicines for the treatment of primary mitochondrial diseases. Abliva AB was incorporated in 2000 and is headquartered in Lund, Sweden. ABLIVA AB is traded on OTC Exchange in the United States.Things to note about Abliva AB performance evaluation
Checking the ongoing alerts about Abliva AB for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Abliva AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abliva AB is not yet fully synchronised with the market data | |
| Abliva AB has some characteristics of a very speculative penny stock | |
| Abliva AB has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 151 K. Net Loss for the year was (123.49 M) with loss before overhead, payroll, taxes, and interest of (103.54 M). | |
| Abliva AB has accumulated about 4.32 M in cash with (114.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Abliva AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abliva AB's stock is overvalued or undervalued compared to its peers.
- Examining Abliva AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abliva AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abliva AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abliva AB's pink sheet. These opinions can provide insight into Abliva AB's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Abliva Pink Sheet
If you are still planning to invest in Abliva AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abliva AB's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |